SYNERCID

This brand name is authorized in United States, South Africa

Active ingredients

The drug SYNERCID contains a combination of these active pharmaceutical ingredients (APIs):

1 Quinupristin UNII 23OW28RS7P - QUINUPRISTIN

Read about Quinupristin

2 Dalfopristin UNII R9M4FJE48E - DALFOPRISTIN

Read about Dalfopristin

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
SYNERCID Powder for solution for injection	FDA, National Drug Code (US)	MPI, US: SPL/Old

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J01FG02	Quinupristin/dalfopristin	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01F Macrolides, lincosamides and streptogramins → J01FG Streptogramins
Discover more medicines within J01FG02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: US	FDA, National Drug Code	Identifier(s): 61570-260
Country: ZA	Health Products Regulatory Authority	Identifier(s): 35/20.1.1/0006